v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2024 $ 2 $ 1,641 $ (5,725) $ (4,082)
Beginning balance (in shares) at Dec. 31, 2024 16,320,839      
Stock-based compensation   32   32
Issuance of restricted stock awards (in Shares) 14,411      
Net loss     (3,137) (3,137)
Ending balance at Mar. 31, 2025 $ 2 1,673 (8,862) (7,187)
Ending balance (in shares) at Mar. 31, 2025 16,335,250      
Beginning balance at Dec. 31, 2024 $ 2 1,641 (5,725) (4,082)
Beginning balance (in shares) at Dec. 31, 2024 16,320,839      
Net loss       (6,936)
Ending balance at Jun. 30, 2025 $ 2 1,869 (12,661) (10,790)
Ending balance (in shares) at Jun. 30, 2025 16,257,304      
Beginning balance at Mar. 31, 2025 $ 2 1,673 (8,862) (7,187)
Beginning balance (in shares) at Mar. 31, 2025 16,335,250      
Stock-based compensation   196   196
Cancellation/forfeiture of restricted stock awards (in Shares) (77,946)      
Net loss     (3,799) (3,799)
Ending balance at Jun. 30, 2025 $ 2 1,869 (12,661) (10,790)
Ending balance (in shares) at Jun. 30, 2025 16,257,304      
Beginning balance at Dec. 31, 2025 $ 5 89,009 (66,727) $ 22,287
Beginning balance (in shares) at Dec. 31, 2025 51,099,089     51,099,089
Stock-based compensation   9,838   $ 9,838
Modification of RSU liability award   2,203   2,203
Vesting of restricted stock units (in shares) 185,000      
Issuance of private placement common stock $ 1 79,999   80,000
Issuance of private placement common stock (in shares) 5,333,333      
Offering costs   (4,851)   (4,851)
Issuance of placement agent warrants (equity component)   1,239   1,239
Issuance costs - placement agent warrants (non-cash)   (1,239)   (1,239)
Net loss     (21,344) (21,344)
Ending balance at Mar. 31, 2026 $ 6 176,198 (88,071) 88,133
Ending balance (in shares) at Mar. 31, 2026 56,617,422      
Beginning balance at Dec. 31, 2025 $ 5 89,009 (66,727) $ 22,287
Beginning balance (in shares) at Dec. 31, 2025 51,099,089     51,099,089
Net loss       $ (52,353)
Ending balance at Jun. 30, 2026 $ 6 217,829 (119,080) $ 98,755
Ending balance (in shares) at Jun. 30, 2026 59,745,938     59,745,938
Beginning balance at Mar. 31, 2026 $ 6 176,198 (88,071) $ 88,133
Beginning balance (in shares) at Mar. 31, 2026 56,617,422      
Stock-based compensation   7,340   7,340
Vesting of restricted stock units (in shares) 430,000      
Issuance of initial public offering common stock   40,000   40,000
Issuance of initial public offering common stock (in Shares) 2,500,000      
Underwriting discounts and offering costs related to the initial public offering   (5,709)   (5,709)
Issuance of common stock for cashless exercise of equity component warrants (in Shares) 9,815      
Issuance of common stock to former SAFE note holders (in Shares) 188,701      
Net loss     (31,009) (31,009)
Ending balance at Jun. 30, 2026 $ 6 $ 217,829 $ (119,080) $ 98,755
Ending balance (in shares) at Jun. 30, 2026 59,745,938     59,745,938